EINDURA

What this means for you

Not registered yet, but its 08 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99433753

Mark type

Stylized text

Filed

08 Oct 2025

Attorney of record

Kristin H. Altoff

Goods and services

• Class 005 — Pharmaceuticals: Biologics in the nature of cells for medical use, namely, covalent protein biologics; synthetic biology enabled covalent therapeutics and covalent peptide drugs and covalent protein drugs for the treatment of cancer, immune and inflammatory conditions, and metabolic diseases and disorders; libraries of covalent protein drugs and covalent peptide drugs for the treatment of cancer, immune and inflammatory conditions, and metabolic diseases and disorders; covalent antibodies for medical purposes
• Class 042 — Scientific and technological services: Research and development in the field of covalent protein biologics; research and development of synthetic peptides containing covalent activation; research and development in the field of synthetic biology enabled covalent therapeutics and covalent peptide drugs and protein drugs; research and development for the purpose of selective covalent modification of peptides and proteins; research and development in the field of covalent protein drugs, namely, development of a platform technology for identification of covalent binding small-molecule and biologic therapeutics; research and development services for the purpose of engineering covalent antibodies

Owner

• Eindura Therapeutics, Inc., Boston, MA, US

Prosecution history

• 10 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 10 Mar 2026 — NON-FINAL ACTION E-MAILED
• 10 Mar 2026 — NON-FINAL ACTION WRITTEN
• 26 Feb 2026 — ASSIGNED TO EXAMINER
• 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 08 Oct 2025 — NEW APPLICATION ENTERED
• 08 Oct 2025 — APPLICATION FILING RECEIPT MAILED